Published on in Vol 5, No 4 (2019): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12016, first published .
Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

Authors of this article:

Simon de Lusignan1, BSc, MSc, MD Author Orcid Image ;   Ana Correa1, MSc Author Orcid Image ;   Gaël Dos Santos2, PhD Author Orcid Image ;   Nadia Meyer2, MD, MPH Author Orcid Image ;   François Haguinet2, MSc Author Orcid Image ;   Rebecca Webb1, BSc Author Orcid Image ;   Christopher McGee1, 3, BSc Author Orcid Image ;   Rachel Byford1, BSc Author Orcid Image ;   Ivelina Yonova1, 3, MSc Author Orcid Image ;   Sameera Pathirannehelage1, BSc Author Orcid Image ;   Filipa Matos Ferreira1, PhD Author Orcid Image ;   Simon Jones1, 4, PhD Author Orcid Image
Article Authors Cited by Tweetations Metrics

Human Vaccines & Immunotherapeutics

Citations:
Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives

Drug Safety

Citations:
Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season

Advances in Therapy

Citations:
Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis